These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 22576309
1. Protein Z polymorphisms associated with vaso-occlusive crisis in young sickle cell disease patients. Mahdi N, Abu-Hijleh TM, Abu-Hijleh FM, Sater MS, Al-Ola K, Almawi WY. Ann Hematol; 2012 Aug; 91(8):1215-20. PubMed ID: 22576309 [Abstract] [Full Text] [Related]
2. Protein Z variants associated with protein Z plasma levels and with risk of idiopathic recurrent miscarriage. Al-Shaikh FS, Sater MS, Finan RR, Racoubian E, Abu-Hijleh TM, Mustafa FE, Almawi WY. Reprod Sci; 2013 Sep; 20(9):1062-8. PubMed ID: 23420821 [Abstract] [Full Text] [Related]
3. Human platelet alloantigens (HPA) 1, HPA2, HPA3, HPA4, and HPA5 polymorphisms in sickle cell anemia patients with vaso-occlusive crisis. Al-Subaie AM, Fawaz NA, Mahdi N, Al-Absi IK, Al-Ola K, Ameen G, Almawi WY. Eur J Haematol; 2009 Dec 01; 83(6):579-85. PubMed ID: 19702628 [Abstract] [Full Text] [Related]
4. The relation of vascular endothelial growth factor (VEGF) gene polymorphisms on VEGF levels and the risk of vasoocclusive crisis in sickle cell disease. Al-Habboubi HH, Mahdi N, Abu-Hijleh TM, Abu-Hijleh FM, Sater MS, Almawi WY. Eur J Haematol; 2012 Nov 01; 89(5):403-9. PubMed ID: 22925497 [Abstract] [Full Text] [Related]
5. Association of variant alleles of MBL2 gene with vasoocclusive crisis in children with sickle cell anemia. Mendonça TF, Oliveira MC, Vasconcelos LR, Pereira LM, Moura P, Bezerra MA, Santos MN, Araújo AS, Cavalcanti MS. Blood Cells Mol Dis; 2010 Apr 15; 44(4):224-8. PubMed ID: 20172753 [Abstract] [Full Text] [Related]
6. Protein Z and Endothelin-1 genetic polymorphisms in pediatric Egyptian sickle cell disease patients. Khorshied MM, Mohamed NS, Hamza RS, Ali RM, El-Ghamrawy MK. J Clin Lab Anal; 2018 Feb 15; 32(2):. PubMed ID: 28548215 [Abstract] [Full Text] [Related]
7. Cytokine profile of sickle cell disease in Oman. Pathare A, Al Kindi S, Alnaqdy AA, Daar S, Knox-Macaulay H, Dennison D. Am J Hematol; 2004 Dec 15; 77(4):323-8. PubMed ID: 15551290 [Abstract] [Full Text] [Related]
8. Depression, anxiety, and stress comorbidities in sickle cell anemia patients with vaso-occlusive crisis. Mahdi N, Al-Ola K, Khalek NA, Almawi WY. J Pediatr Hematol Oncol; 2010 Jul 15; 32(5):345-9. PubMed ID: 20485202 [Abstract] [Full Text] [Related]
9. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease. Ender KL, Krajewski JA, Babineau J, Tresgallo M, Schechter W, Saroyan JM, Kharbanda A. Pediatr Blood Cancer; 2014 Apr 15; 61(4):693-6. PubMed ID: 24249617 [Abstract] [Full Text] [Related]
10. Anti-annexin V IgG and IgM antibodies in sickle cell disease patients with vaso-occlusive crisis. Sater MS, Mahdi N, Al-Absi IK, Al-Subaie AM, Al-Ola K, Mohammed FA, Almawi WY. Ann Hematol; 2011 Sep 15; 90(9):1031-6. PubMed ID: 21340721 [Abstract] [Full Text] [Related]
11. Serum IL-6, IL-10, and TNFα levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition. Sarray S, Saleh LR, Lisa Saldanha F, Al-Habboubi HH, Mahdi N, Almawi WY. Cytokine; 2015 Mar 15; 72(1):43-7. PubMed ID: 25569375 [Abstract] [Full Text] [Related]
12. Sickle cell vaso-occlusive crisis is associated with abnormalities in the ratio of vasoconstrictor to vasodilator prostanoids. Setty BN, Chen D, Stuart MJ. Pediatr Res; 1995 Jul 15; 38(1):95-102. PubMed ID: 7478805 [Abstract] [Full Text] [Related]
13. Markers of endothelial dysfunction and leucocyte activation in Saudi and non-Saudi haplotypes of sickle cell disease. Al Najjar S, Adam S, Ahmed N, Qari M. Ann Hematol; 2017 Jan 15; 96(1):141-146. PubMed ID: 27686084 [Abstract] [Full Text] [Related]
14. Arterialization of venous blood for differentiation of sickle cell subjects in vaso-occlusive crisis. Nahavandi M, Tavakkoli F, Wyche MQ, Perlin E, Millis RM. Hematology; 2003 Dec 15; 8(6):421-8. PubMed ID: 14668039 [Abstract] [Full Text] [Related]
15. Evaluation of reticulated platelets in patients with sickle cell diseases. Noronha JF, Costa FF, Saad ST, Lorand-Metze IG, Grotto HZ. Thromb Res; 2007 Dec 15; 121(2):259-67. PubMed ID: 17521711 [Abstract] [Full Text] [Related]
16. Frequency of the 677 C-->T mutation of the methylenetetrahydrofolate reductase gene among Kuwaiti sickle cell disease patients. Adekile AD, Kutlar F, Haider MZ, Kutlar A. Am J Hematol; 2001 Apr 15; 66(4):263-6. PubMed ID: 11279637 [Abstract] [Full Text] [Related]
17. Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population). Elshazly SA, Heiba NM, Abdelmageed WM. Hematology; 2014 Jan 15; 19(1):52-9. PubMed ID: 23735470 [Abstract] [Full Text] [Related]
18. Plasma levels of TNF-alpha in sickle cell patients receiving hydroxyurea. Tavakkoli F, Nahavandi M, Wyche MQ, Perlin E. Hematology; 2004 Feb 15; 9(1):61-4. PubMed ID: 14965870 [Abstract] [Full Text] [Related]
19. Pulmonary function studies in Kuwaiti children with sickle cell disease and elevated Hb F. Hijazi Z, Onadeko BO, Khadadah M, Haider MZ, Adekile AD, Al-Habashi H. Int J Clin Pract; 2005 Feb 15; 59(2):163-7. PubMed ID: 15854191 [Abstract] [Full Text] [Related]
20. Types of crises in sickle cell disease patients presenting at the haematology day care unit (HDCU), University College Hospital (UCH), Ibadan. Olabode JO, Shokunbi WA. West Afr J Med; 2006 Feb 15; 25(4):284-8. PubMed ID: 17402517 [Abstract] [Full Text] [Related] Page: [Next] [New Search]